Group Mailing 2000-06-01

Priority Lists

Disease Committee	Last Changed
Breast Cancer	11/1/23
Cancer Care Delivery	9/1/22
Cancer Survivorship	1/14/19
comboMATCH	12/1/23
Early Therapeutics & Rare Cancers	12/1/23
Gastrointestinal Cancer	12/1/23
Genitourinary Cancer	12/1/23
Head and Neck Cancer	12/15/07
iMATCH	11/1/22
Immunomolecular Therapeutics	6/15/20
Leukemia	3/22/23
Lung Cancer	12/1/23
LungMAP	12/15/23
Lymphoma	1/17/24
Melanoma	4/18/22
Myeloma	4/1/24
Other	2/1/14
Prevention & Epidemiology	7/1/24
Symptom Control and Quality of Life	4/1/23

S9712Phase II

Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol®) For Poor-Risk Stage III Non-Small Cell Lung Cancer

Study Coordinator(s)	Derick H.M. Lau, M.D.,Ph.D., David R. Gandara, M.D., Laurie E. Gaspar, M.D.
Participants	Members, NCORP
Closure Date	2000-06-01

S0008Phase III Intergroup

Phase III Trial of High Dose Interferon Alpha-2b versus Cisplatin, Vinblastine, DTIC Plus IL-2 and Interferon in Patients with High Risk Melanoma

Study Coordinator(s)	Lawrence E. Flaherty, M.D., John A. Thompson, M.D., Ralph J. Tuthill, M.D., John Vetto, M.D., Vernon K. Sondak, M.D., Jeffrey A. Sosman, M.D.
Participants	Members, NCORP, Medical Oncologists, Surgeons, Pathologists, ECOG, COG, US INSTITUTIONS ONLY